Conference Correspondent

Immunotherapy for Advanced Prostate Cancer May Be Underutilized

Sipuleucel-T for metastatic castrate-resistant prostate cancer (mCRPC) offers a novel immunotherapy treatment option for a subset of patients, but the drug could be helping far more men than actually receive it, according to a speaker at the 37th Annual Congress of the Oncology Nursing Society. Sipuleucel-T, which activates T cells [ Read More ]

Global Biomarkers Consortium — Implementing the Promise of Personalized Cancer Care

The inaugural conference of the Global Biomarkers Consortium brought together an international panel of oncology experts to explore the rapidly evolving field of biomarker research. Cochairs of the event were Hope S. Rugo, MD, director of Breast Oncology and Clinical Trials Education at the University of California San Francisco, and [ Read More ]

« Previous 1 2 3